Business
Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings
Revenue of $296.5 million in Q4 and $1,137.8 million in fiscal 2025Organic revenue grew 7.9% in Q4 and 1.2% in fiscal 2025Diluted EPS of $4.29 in fiscal 2025; Adjusted fiscal 2025 Diluted EPS of $4.52 grew 7.4% versus adjusted prior yearReduced leverage to 2.4x at year-end driven by strong free cash flow and EBITDA growthInitial fiscal 2026 organic revenue growth and Diluted EPS outlook of approximately 1% to 2% and $4.70 to $4.82, respectively TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- P
About this update from Prestige Consumer Healthcare Inc.
[{"type":"image","alt":"Prestige Consumer Healthcare Inc.","displaySize":"","headline":null,"caption":"Prestige Consumer Healthcare Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":102,"url":"https://media.zenfs.com/en/globenewswire.com/1b5655ca12a92f858081df51ed2ce36b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/FLwmlDskH0PHRRLgz3xb6Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/1b5655ca12a92f858081df51ed2ce36b","width":300,"height":102}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue of $296.5 million in Q4 and $1,137.8 million in fiscal 2025","length":67,"tagName":"p"}]},{"val":[{"type":"text","content":"Organic revenue grew 7.9% in Q4 and 1.2% in fiscal 2025","length":55,"tagName":"p"}]},{"val":[{"type":"text","content":"Diluted EPS of $4.29 in fiscal 2025; Adjusted fiscal 2025 Diluted EPS of $4.52 grew 7.4% versus adjusted prior year","length":115,"tagName":"p"}]},{"val":[{"type":"text","content":"Reduced leverage to 2.4x at year-end driven by strong free cash flow and EBITDA growth","length":86,"tagName":"p"}]},{"val":[{"type":"text","content":"Initial fiscal 2026 organic revenue growth and Diluted EPS outlook of approximately 1% to 2% and $4.70 to $4.82, respectively","length":125,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":448,"olType":false},{"type":"text","content":"TARRYTOWN, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2025.","length":194,"tagName":"p"},{"type":"text","content":"“We are very pleased with our fiscal year results, which delivered another year of consistent sales and earnings per share growth. The record fourth quarter sales performance exceeded our expectations, driven by continued International business strength, growth in a wide range of categories and brands in North America, and the success of the eCommerce channel thanks to our long-term investments and broad distribution. The resulting earnings growth translated into strong free cash flow which amplified shareholder returns through a continued disciplined capital allocation approach that included share repurchases, M&A, and deleveraging in the fiscal year,” said Ron Lombardi, Chief Executi...